Clinical Trial Update: The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea [Phase 3]

View source ↗

Summary

Phase 3 trial assessing low flow nocturnal oxygen therapy in patients with heart failure and central sleep apnea was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Sleep Apnea
• Heart Failure

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Heart Failure, Central Sleep Apnea | Phase 3 | Status: TERMINATED | Results posted: 2023-08-01